Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home » 2019

2019

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 27/04/20 by Alan S. Wilkinson

Drug sterility is maintained in Luer Lock (LL) syringes fitted with Tevadaptor syringe adaptor lock (SAL) according to NHS yellow cover document syringe integrity standards

View resources
Last reviewed: 17/03/21 by Himanshu Patel

Educational needs of oncology pharmacists: A survey report from the International Society of Oncology Pharmacy Practitioners (ISOPP)

Abstracts

View resources
Last reviewed: 27/04/20 by Deborah Peoples

Evaluation of palbociclib usage in patients with metastatic breast cancer at the North West Cancer Centre, Altnagelvin Area Hospital

View resources
Last reviewed: 27/04/20 by Siobhan Smith

Exploring the feasibility of IGEV delivery through an ambulatory service

View resources
Last reviewed: 27/04/20 by Rebecca Burgoyne

Fixed dose 7.5mg rasburicase is safe and cost-effective in preventing tumour lysis syndrome in adult haematology patients at University College London Hospitals NHS Trust

View resources
Last reviewed: 12/10/20 by Laura J. Miller

Height and weight reporting frequency for BSA and weight prescribed chemotherapy and its impact on weight change interpretation in an acute hospital? A retrospective audit

Abstracts

View resources
Last reviewed: 12/10/20 by Pinkie Chambers

How and where do patients present with immunotherapy adverse events?

Abstracts

View resources
Last reviewed: 27/04/20 by Idalia Dávila-González

Hypersensitivity reactions to chemotherapy drugs in a public hospital Mexican

View resources
Last reviewed: 17/03/21 by Jenny Allen

Impact assessment of a novel chemotherapy medicines assistant role

Abstracts

View resources
Last reviewed: 17/03/21 by Yi Long Toh

Impact of chemotherapy regimen type on plasma DHEA(S) and cognitive function in early-stage breast cancer patients

Abstracts

View resources
Last reviewed: 27/04/20 by Caterina Donati

Impact of fully automated chemotherapy preparation on safety, performances, and workflow in an Italian multisite cancer center

View resources
Last reviewed: 12/10/20 by Kavita Kantilal

Implementation of a pharmacist-led oral systemic anti-cancer therapies clinic

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 12 13 14 … 18 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.